Skip to main content
Premium Trial:

Request an Annual Quote

Canopy Biosciences COVID-19 Immune Response Assay

Canopy Biosciences, a Bruker company, has launched the research-use-only COVID-19 Immune Response Assay for use on Canopy's ZellScannerOne spatial phenotyping instrument. ZellScannerOne enables multiplexed spatial quantification of protein biomarkers in tissue samples and suspended cells. The new assay can spatially profile 18 different protein biomarkers, and the data it generates enables the identification and quantification of 32 distinct cellular phenotypes, including major immune cell types and various cell states. Canopy said the assay will be available initially as a service, with a reagent kit to follow at a later date.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.